The effect of Ganoderm on glycemic control in diabetic patients
Phase 3
Recruiting
- Conditions
- Diabetes mellitus type 2.Type 2 diabetes mellitus
- Registration Number
- IRCT20200716048118N1
- Lead Sponsor
- Yas Daru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Type 2 Diabetic patients
age 30-70
HbA1c 8-10%
Exclusion Criteria
liver failure
renal failure
pregnant women
lactating women
insulin therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose. Timepoint: Begging and at after 12 weeks of treatment. Method of measurement: Biochemical method and autoanalyser.
- Secondary Outcome Measures
Name Time Method Cholesterol Total. Timepoint: Triglyceride. Method of measurement: Biochemistry- Calorimetry.